MCAZ Begins Border Medicine Screening

The Medicines Control Authority of Zimbabwe will begin screening imported medicines at the country's ports of entry. This operational shift moves regulatory enforcement directly to border points rather than relying solely on post-import market surveillance. The initiative targets the inflow of pharmaceutical products that bypass existing safety verification channels. MCAZ positions the border screening as a frontline defense against substandard or unauthorized medicines entering the domestic supply chain. Port-of-entry screening capability determines the effectiveness of pharmaceutical import controls.